Delivery Order SPE2DB25D3108-SPE2DB25FPDLS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,779.14 to AmerisourceBergen Drug Corp for Shingrix vial kits, with a completion date of July 22, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $4,371.95 to AmerisourceBergen Drug Corp for Shingrix vial kits, effective July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $11,391.80 to AmerisourceBergen Drug Corp for the supply of Shingrix vial kits, with a completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. The delivery will be fulfilled from the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,391.80 by the Defense Logistics Agency on July 21, 2025, for the supply of Shingrix vial kits. This firm fixed-price contract represents a non-set-aside competitive award with an ultimate completion date of July 22, 2025. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This delivery order, valued at $1,558.34, was awarded to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Shingrix vial kits. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense responsible for supplying medical and pharmaceutical products to military and veteran healthcare systems. The contract is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and will be performed at AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $79,544.85 on July 24, 2025, for the supply of Shingrix vaccine vials (10-dose kits) under a firm fixed-price contract. The award is not set-aside and carries an ultimate completion date of August 20, 2025. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of SHINGRIX vial kits. The award, valued at $26,189.83, is a one-time delivery order and does not have any set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 31,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide SHINGRIX vaccine vials. The delivery order, valued at $6,513.31, is a firm fixed price contract with an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor. This delivery order is part of a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide SHINGRIX vial kits. The $1,683.08 contract has a completion date of January 11, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that has received numerous awards from DLA to supply pharmaceuticals, medical supplies, and distribution services in support of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide SHINGRIX VIAL KITS with a ceiling value of $2,208.16. The contract has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is delivering these pharmaceutical products to support military treatment programs and facilities. This delivery order is part of a larger...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPDLSDelivery Order
The Defense Logistics Agency awarded a $4,333.37 firm fixed price delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of July 29, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and a primary distribution center for federal medical procurement. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing comprehensive medical supplies and medications to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Shingrix is a recombinant zoster vaccine indicated for the prevention of herpes zoster, commonly known as shingles, and represents part of the company's extensive portfolio of vaccines and specialty pharmaceuticals supplied to military and veteran healthcare systems. This delivery order exemplifies the company's role as a critical vendor within the DLA's Medical Supply Chain, fulfilling routine pharmaceutical procurement needs through competitively awarded contracts with firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 7/28/25 |